Analysis for Morgan Stanley
Analysis summary
Morgan Stanley (MS) currently has a total score of 68 points, placing it in the strong range. The score is made up of Performance (82), Stability (52) and Trend (55). The profile is clearly uneven: Performance stands out while Stability is more neutral.
Performance scores 82 points (very strong). Key strength: 10Y return at 657.5 %. Even the weakest return is still strong in absolute terms: 1Y return at 25.5 %. This suggests stronger long-term than short-term performance.
Stability scores 52 points (neutral). Key strength: CAGR/drawdown ratio at 0.43. Weaker metric: volatility (365d, annualized) at 31.6 %. That implies elevated swings. Higher Stability points are better and typically reflect calmer swings and smaller drawdowns—but prices can still fall.
Trend scores 55 points (neutral). Key strength: 12M momentum at 39.7 %. Weaker signal: Price is about 4.7 % below SMA50.
Overall, the profile has a clear strength in Performance, while Stability is the main limiter. On a metric level, 10Y return stands out, while SMA50 distance is the main weak spot.
(Historical evaluation, not investment advice.)
Metrics
Performance
Stability
FAQ
- What investor type does Morgan Stanley fit best in FoxScore?
- Morgan Stanley fits a more opportunity-seeking investor type in FoxScore: performance is the strongest sub-score. That suggests above-average historical returns — but check stability to ensure the performance wasn’t “paid for” with high volatility or deep drawdowns.
- How meaningful is the available history for Morgan Stanley?
- Morgan Stanley currently has about 15 years of price history available. That covers multiple market cycles including crisis phases, making long-term interpretation of returns, drawdowns and trend shifts more reliable.
- What is FoxScore good for — and what is it not for?
- FoxScore is an analysis and comparison tool: it helps you sort assets quickly, compare profiles and spot strengths/weaknesses. It’s not a substitute for your own research or fundamental analysis, and it’s not a buy/sell recommendation.